Lurasidone for the treatment of schizophrenia: pooled analysis of short-term, placebo-controlled trials

被引：0
|
作者：
Murthy, V. [1 ]
Cucchiaro, J. [2 ]
Pikalov, A. [3 ]
Xu, J. [2 ]
Loebel, A. [3 ]
机构：
[1] Takeda Dev Ctr Europe, Clin Dev, London, England
[2] Sunovion Pharmaceut Inc, Clin Dev, Ft Lee, NJ 07024 USA
[3] Sunovion Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ 07024 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70769-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.046
引用
收藏
页码：S485 / S486
页数：2
相关论文
共 50 条
  • [21] EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS: A POST-HOC ANALYSIS OF SHORT-TERM TRIALS
    Pikalov, Andrei
    Schooler, Nina
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S355 - S355
  • [22] Efficacy of Lurasidone in the Treatment of Schizophrenia with Prominent Negative Symptoms: A Post-hoc Analysis of Short-term Trials
    Schooler, Nina R.
    Pikalov, Andrei
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S513 - S514
  • [23] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: A post-hoc analysis of short-term trials
    Schooler, N. R.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Goldman, R.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 151 - 152
  • [24] LURASIDONE FOR SCHIZOPHRENIA: SYMPTOMATIC REMISSION DURING SHORT-TERM TREATMENT
    Guarino, John
    Loebel, A.
    Cucchiaro, J.
    Ogasa, M.
    Silva, R.
    Siu, C.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 373 - 373
  • [25] Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
    Nakamura, Mitsutaka
    Ogasa, Masaaki
    Guarino, John
    Phillips, Debra
    Severs, Joseph
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (06) : 829 - 836
  • [26] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: Results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S79 - S80
  • [27] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66
  • [28] SYMPTOM IMPROVEMENT ASSOCIATED WITH LURASIDONE TREATMENT OF CHILDREN AND ADOLESCENTS WITH BIPOLAR I DEPRESSION: RESULTS OF A SHORT-TERM PLACEBO-CONTROLLED TRIAL
    Singh, Manpreet K.
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S271 - S272
  • [29] Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies
    Davis, Craig W.
    Kallweit, Ulf
    Schwartz, Jean-Charles
    Krahn, Lois E.
    Vaughn, Ben
    Thorpy, Michael J.
    SLEEP MEDICINE, 2021, 81 : 210 - 217
  • [30] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: a post-hoc analysis of five short-term trials
    Schooler, N. R.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Goldman, R.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S558 - S558
12345